header logo image

CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day

February 7th, 2021 3:51 am

ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 05, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the Guggenheim Healthcare Talks 2021 Oncology Day on Friday, February 12, 2021, at 3:30 p.m. ET.

More here:
CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick